Literature DB >> 23873015

Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population.

Zhen-Bin Ma1, Kun Li, Jian Wang, Guang-Hong Guo.   

Abstract

The aim of this study is to investigate the associations between KAI1/CD82 gene polymorphisms and colorectal cancer (CRC)-risk predisposition. We undertook a case-control study to analyze two KAI1/CD82 polymorphisms (exon 3 -29166 C>T and exon 9 -52840 C>A) in an Han Chinese population, by extraction of genomic DNA from the peripheral blood of 356 patients with CRC and 378 control participants, and performed KAI1/CD82 genotyping using DNA sequencing. The obtained results indicated that overall, no statistically significant association was observed in exon 9 (-52840 C>A). Nevertheless, exon 3 (-29166 C>T) genotype was at increased risk of CRC (P = 0.006; odds ratio = 1.299, CI 95% 1.058-1.549). Furthermore, -29166 T allele CRCs were more significantly common in patients with tumor size of >4 cm than C allele CRC and in cases of poor differentiation and advanced pathological stage. These findings led us to conclude that polymorphism in exon 3 (-29166 C>T) was observed to be associated with susceptibility of CRC. However, exon 9 (-52840 C>A) polymorphism showed no correlation to CRC susceptibility. Nevertheless, further investigation with a larger sample size is needed to support our results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873015     DOI: 10.1007/s12032-013-0668-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  32 in total

1.  Strategies for colon cancer screening with considerations of cost and access to care.

Authors:  Randall W Burt
Journal:  J Natl Compr Canc Netw       Date:  2010-01       Impact factor: 11.908

Review 2.  The ins and outs of the transmembrane 4 superfamily.

Authors:  M D Wright; M G Tomlinson
Journal:  Immunol Today       Date:  1994-12

3.  Carcinoma of the colon: long-term survival and prognosis after surgical treatment in a series of 798 patients.

Authors:  J Moreaux; M Catala
Journal:  World J Surg       Date:  1987-12       Impact factor: 3.352

4.  A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis.

Authors:  M Miyake; S I Hakomori
Journal:  Biochemistry       Date:  1991-04-02       Impact factor: 3.162

5.  [Efficacy and side effects of combination therapy of oxaliplatin and S-1 for colorectal cancer].

Authors:  Qing-chao Zhu; Zhi-ming Jin
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2011-05

6.  Genomic organization of the human KAI1 metastasis-suppressor gene.

Authors:  J T Dong; W B Isaacs; J C Barrett; J T Isaacs
Journal:  Genomics       Date:  1997-04-01       Impact factor: 5.736

7.  High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.

Authors:  Katsuhiro Uzawa; Kanae Ono; Hiroyoshi Suzuki; Chihaya Tanaka; Takashi Yakushiji; Nobuharu Yamamoto; Hidetaka Yokoe; Hideki Tanzawa
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

8.  Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer.

Authors:  Y Hinoda; Y Adachi; A Takaoka; H Mitsuuchi; Y Satoh; F Itoh; Y Kondoh; K Imai
Journal:  Cancer Lett       Date:  1998-07-17       Impact factor: 8.679

9.  EWI-2 modulates lymphocyte integrin alpha4beta1 functions.

Authors:  Tatiana V Kolesnikova; Christopher S Stipp; Ravi M Rao; William S Lane; Francis W Luscinskas; Martin E Hemler
Journal:  Blood       Date:  2003-12-18       Impact factor: 22.113

10.  Clinical significance of transmembrane 4 superfamily in colon cancer.

Authors:  H Hashida; A Takabayashi; T Tokuhara; N Hattori; T Taki; H Hasegawa; S Satoh; N Kobayashi; Y Yamaoka; M Miyake
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more
  5 in total

1.  Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.

Authors:  Qing-Hui Zhang; Yong-Liang Yao; Xiao-Yang Wu; Jian-Hong Wu; Tao Gu; Ling Chen; Jin-Hua Gu; Yun Liu; Ling Xu
Journal:  Dig Dis Sci       Date:  2015-02-05       Impact factor: 3.199

2.  Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population.

Authors:  Jian Wang; Zhen-Bin Ma; Kun Li; Guang-Hong Guo
Journal:  Med Oncol       Date:  2014-02-02       Impact factor: 3.064

3.  Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma.

Authors:  Gengming Wang; Hao Jiang; Hongbo Xu; Qian Sun; Yan Zhou; Ping Xiang; Zenong Cheng; Yajun Zhang; Yufu Zhou; Qing Guo; Xinglong DU; Shuxiu Xu; Shiyin Ma; Zhendong Chen
Journal:  Oncol Lett       Date:  2015-01-23       Impact factor: 2.967

4.  A functional variant at miR-520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population.

Authors:  Lifang Ding; Zao Jiang; Qiaoyun Chen; Rong Qin; Yue Fang; Hao Li
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

5.  Investigations of a Possible Role of SNPs in KAI1 Gene on Its Down-Regulation in Breast Cancer.

Authors:  Haitham Kussaibi; Khaled R Alkharsah
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.